Softhale
Respiratory drug/device for the treatment of asthma & COPD

Hundreds of millions of people are burdened with a chronic respiratory condition – the WHO estimates that 235 million people currently have asthma, and four million die prematurely from chronic respiratory disease (COPD) every year.

Softhale’s vision is to create a new generation of eco-friendly medical inhalation products to improve respiratory treatments.

Our Mission is to:
  • Intensify and expand the use of propellant-free and therefore eco-friendly device solutions
  • Offer patients innovative soft-mist inhalation applications on a global scale
  • Create a proprietary device platform, flexible enough to adapt to multiple indications that can be treated via the respiratory pathway

Learn more at:

https://www.softhale.com/